Acute promyelocytic leukemia

Jump to navigation Jump to search

Template:DiseaseDisorder infobox

Acute promyelocytic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute promyelocytic leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary PreventionSurgery

Secondary PreventionSurgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute promyelocytic leukemia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute promyelocytic leukemia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute promyelocytic leukemia

CDC on Acute promyelocytic leukemia

Acute promyelocytic leukemia in the news

Blogs on Acute promyelocytic leukemia

Directions to Hospitals Treating Acute promyelocytic leukemia

Risk calculators and risk factors for Acute promyelocytic leukemia

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Grammar Reviewer: Natalie Harpenau, B.S.[2]

Synonyms and keywords: Acute progranulocytic leukemia; APL; AML with t(15;17)(q22;q12); PML-RARA and variants; FAB subtype M3; M3 variant

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Acute promyelocytic leukemia from Other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Other Imaging studies | Other Diagnostic Studies

Treatment

Medical Therapy | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

de:Promyelozytenleukämie

Template:WikiDoc Sources